PFIZER

French drugmaker Sanofi-Aventis expanded its animal health business by buying the other half of Merial from its U.S. partner Merck for $4 billion in cash while opening the door for a bigger deal.

Swiss drugmaker Roche gave a bullish forecast for the next two years on the back of its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu.

Three of the world's biggest drugmakers posted better-than-expected quarterly earnings on Wednesday and gave bullish forecasts for the rest of the year, demonstrating the industry's resilience in the weak economy.

Three of the world's biggest drugmakers posted better-than-expected quarterly earnings on Wednesday and gave bullish forecasts for the rest of the year, demonstrating the industry's resilience in the weak economy.

Pfizer Inc said on Wednesday its second-quarter earnings fell 19 percent, as the strong dollar crimped revenue across its product line.

U.S. stock index futures pointed to a lower open on Wall Street on Wednesday, following recent gains, as investors braced themselves for more results from bellwethers such as Morgan Stanley , PepsiCo , Pfizer , Boeing and Wells Fargo .

European Union antitrust authorities cleared U.S. drugmaker Pfizer's $68 billion takeover of rival Wyeth on Friday subject to conditions, notably the divestment of animal vaccines.

Roche Holding AG's Tarceva cancer drug improved the survival of patients with advanced lung cancer when used immediately after initial chemotherapy, the Swiss group said on Monday.

Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.

Johnson & Johnson is take over most of Elan Corp Alzheimer's research and invest $1 billion in new Elan equity in exchange for an 18.4 percent stake in the Irish drugmaker, the companies said on Thursday.

Swiss drugmaker Novartis is in talks to buy parts of Irish peer Elan , including its flagship multiple sclerosis products and its Alzheimer's disease pipeline, the Sunday Times said.

The new bosses at Sanofi-Aventis and GlaxoSmithKline are playing a cautious acquisition game, 13 and seven months respectively after taking control of the two big European drugmakers.

Pfizer Inc's Sutent delayed the worsening of the type of pancreatic cancer that afflicted Apple Inc Chief Executive Steve Jobs by more than five months longer than a placebo, according to data from a clinical trial.

Watson Pharmaceuticals Inc said on Wednesday that it would buy privately held Arrow Group for $1.75 billion, clinching a long-expected deal by the U.S. generic drugmaker to expand internationally.

Watson Pharmaceuticals Inc said on Wednesday it will buy privately held Arrow Group for $1.75 billion, clinching a long-expected deal by the U.S. generic drugmaker to expand internationally.

Pfizer Inc is seeking acquisitions in the Middle East where the company expects to see double digit growth, a Pfizer executive said on Sunday, according to Bloomberg.

Pfizer Inc , the world's largest drugmaker, is looking to conclude deals in emerging markets over few months to raise its share of a market estimated at about $80 billion, an executive said on Sunday.

Technology shares fell on Friday after disappointing results from National Semiconductor, but a rise in defensive stocks, like healthcare, cushioned losses in the Dow and S&P 500.

An experimental cancer pill from GlaxoSmithKline reduced the risk of tumour progression or death by 54 percent in advanced kidney cancer patients compared to placebo, trial results showed on Monday.

Treatment guidelines exist to help physicians choose the best treatment options for their patients based on current scientific studies.

U.S. pharmaceutical giant Pfizer is set to raise $10.6 billion through the sale of a four-part bond, IFR reported on Tuesday, that will help finance its purchase of Wyeth.